Mirko Koziolek is a Principal Research Scientist in Small Molecule CMC Development at AbbVie in Ludwigshafen, Germany. He earned his PhD in Biopharmacy and Pharmaceutical Technology from the University of Greifswald in 2014, under the guidance of Prof. Werner Weitschies. Following his PhD, Mirko completed a postdoctoral fellowship in the group of Prof. Christopher Porter at the Monash Institute of Pharmaceutical Sciences in Melbourne, Australia. In 2016, Mirko returned to the University of Greifswald, focusing his research on the design and optimization of biorelevant in vitro tools (e.g. GastroDuo) and the application of in vivo techniques (e.g. MRI and telemetric capsules), to study the behavior of oral formulations in the human gastrointestinal tract. In 2019, Mirko joined AbbVie, where he is responsible for providing biopharmaceutical support for drug product development. He is the author/co-author of 50+ peer-reviewed publications and regularly reviews for various journals within the field of pharmaceutical sciences.